Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response

NCT04936971 · clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Impossibility to perform tests (elispot) of the study due to change of location of laboratory

Conditions

Interventions

Sponsor

Edoardo Melilli